Skip to content

8-KAccepted Feb 16, 8:30 AM ET

Allogene Therapeutics, Inc. 8-K

ALLOAllogene Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:30 AM

Feb 16, 2024

Filed

Feb 16, 2024

Documents

12

Size

152.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.